GleamWall
中文EN

MOBI Mobia Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1489993 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets12.8%
Debt / equity0.05x
Current ratio11.79x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue$15.62M$13.51M$12.07M$9.01M$6.67M$5.66M
Cost of revenue$2.62M$2.27M$2.13M$1.84M$1.18M$1.01M
Gross profit$13.00M$11.24M$9.94M$7.18M$5.49M$4.65M
R&D expense$2.55M$2.28M$1.69M$1.60M$1.42M$1.35M
SG&A expense$28.98M$26.89M$25.19M$16.83M$14.53M$13.60M
Operating income-$18.53M-$17.93M-$16.94M-$11.26M-$10.46M-$10.30M
Interest expense$257,000$254,000$357,000$244,000$241,000$239,000
Pretax income-$17.34M-$21.04M-$17.74M-$11.42M-$10.49M-$10.65M
Income tax$2,000$2,000$0$1,000$2,000$1,000
Net income-$17.34M-$21.04M-$17.74M-$11.42M-$10.49M-$10.65M
EBITDA-$18.35M-$17.83M-$16.88M-$11.22M-$10.43M-$10.27M
EPS (basic)-0.52-1.10-19.30-13.31-12.44-12.97
EPS (diluted)-0.52-1.10-19.30-13.31-12.44-12.97
Weighted avg. shares (diluted)33.30M19.09M918,935858,354843,168821,160
Balance sheet
Cash & equivalents$160.69M$177.09M$55.73M———
Receivables$7.00M$5.66M$4.85M———
Inventory$8.35M$6.95M$6.05M———
Current assets$178.22M$192.15M$71.71M———
PP&E, net$1.94M$2.06M$738,000———
Total assets$181.17M$195.28M$73.60M———
Current liabilities$15.12M$14.47M$11.83M———
Long-term debt$7.30M$7.28M$7.26M———
Total debt$7.30M$7.28M$7.26M———
Total liabilities$23.26M$22.68M$61.57M———
Shareholders' equity$157.91M$172.61M-$167.75M-$137.33M-$126.35M-$116.28M
Net debt-$153.39M-$169.81M-$48.47M———
Shares outstanding33.33M33.29M1.00M———
Cash flow statement
Operating cash flow-$12.92M-$15.67M-$17.73M-$11.59M-$11.00M-$9.72M
Capital expenditure$58,000$1.54M$42,000$236,000$0$23,000
Free cash flow-$12.98M-$17.21M-$17.77M-$11.83M-$11.00M-$9.75M
Investing cash flow-$58,000-$1.54M-$42,000-$236,000$0-$23,000
Financing cash flow-$3.42M$138.57M$39.91M$37,000$11,000$32.42M
Depreciation & amortization$177,000$100,000$56,000$39,000$32,000$31,000
Stock-based compensation$2.56M$1.61M$407,000$406,000$404,000$201,000

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.